Lord, Abbett & Co. LLC Syndax Pharmaceuticals Inc Transaction History

Lord, Abbett & Co. LLC

$31.4 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 07, 2024	SELL	$14.52 - $21.77 $2.21 Million - $3.31 Million	-152,205 Reduced 41.68%	212,967 $3.09 Million
Q3 2023 Nov 13, 2023	SELL	$14.52 - $21.77 $2.21 Million - $3.31 Million	-152,205 Reduced 41.68%	212,967 $3.09 Million
Q2 2023 Oct 07, 2024	SELL	$19.35 - $22.31 $2.31 Million - $2.67 Million	-119,494 Reduced 24.65%	365,172 $7.64 Million
Q2 2023 Aug 14, 2023	SELL	$19.35 - $22.31 $2.31 Million - $2.67 Million	-119,494 Reduced 24.65%	365,172 $7.64 Million
Q1 2023 Oct 07, 2024	BUY	$20.66 - $28.98 $3.07 Million - $4.31 Million	148,670 Added 44.25%	484,666 $10.2 Million
Q1 2023 May 12, 2023	BUY	$20.66 - $28.98 $3.07 Million - $4.31 Million	148,670 Added 44.25%	484,666 $10.2 Million
Q4 2022 Oct 07, 2024	BUY	$20.64 - $26.24 $6.93 Million - $8.82 Million	335,996 New	335,996 $8.55 Million
Q4 2022 Feb 10, 2023	BUY	$20.64 - $26.24 $21,321 - $27,105	1,033 Added 0.31%	335,996 $8.55 Million
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $371,106 - $497,014	20,049 Added 6.37%	334,963 $8.05 Million
Q2 2022 Aug 12, 2022	BUY	$13.64 - $19.48 $294,146 - $420,086	21,565 Added 7.35%	314,914 $6.06 Million
Q1 2022 May 13, 2022	BUY	$14.84 - $22.15 $78,607 - $117,328	5,297 Added 1.84%	293,349 $5.1 Million
Q4 2021 Feb 11, 2022	SELL	$15.23 - $22.47 $42,522 - $62,736	-2,792 Reduced 0.96%	288,052 $6.31 Million
Q3 2021 Nov 09, 2021	SELL	$13.87 - $19.8 $52,220 - $74,547	-3,765 Reduced 1.28%	290,844 $5.56 Million
Q2 2021 Aug 11, 2021	BUY	$13.42 - $25.18 $3.95 Million - $7.42 Million	294,609 New	294,609 $5.06 Million

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

89.9M

Call Options Held

1.01M

Put Options Held

692K

Black Rock Inc. New York, NY

7.91M
Shares

$112 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

5.84M
Shares

$82.8 Million
9.23% of portfolio
Wellington Management Group LLP Boston, MA

4.99M
Shares

$70.7 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

4.89M
Shares

$69.2 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

4.11M
Shares

$58.2 Million
6.25% of portfolio

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $802M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account